Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome

References

• Krogsgaard L, Engsbro AL, Bytzer P. The prevalence of irritable bowel syndrome (IBS) in Denmark—a web-panel based survey. Scand J Gastroenterol 2010;45(Suppl 247): S46–7.
   PubMedGoogle Scholar
• Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979–88.
   PubMed Web of Science ®Google Scholar
• Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010;156:3205–15.
   PubMed Web of Science ®Google Scholar
• Menees SB, Maneerattannaporn M, Kim HM, Chey WD. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2012;107:28–35.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325–32.
   PubMed Web of Science ®Google Scholar
• Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg MA, et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 2004; 70:383–5.
   PubMedGoogle Scholar
• Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, et al. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis?. Parasitol Res 2010;106:1033–8.
   PubMedGoogle Scholar
• Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, et al. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara, Turkey. PLoS One 2010;5:e15484.
   Google Scholar
• Dogruman-Al F, Kustimur S, Yoshikawa H, Tuncer C, Simsek Z, Tanyuksel M, et al. Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem Inst Oswaldo Cruz 2009;104:724–7.
   PubMedGoogle Scholar
• Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999;18:436–9.
   PubMedGoogle Scholar
• Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero- Valdovinos M, et al. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 2012;110:1269–75.
   PubMed Web of Science ®Google Scholar
• Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010;107:679–84.
   PubMed Web of Science ®Google Scholar
• Borody TJ, Warren EF, Wettstein A, Robertson G, Recabarren P, Fontela A, et al. Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol 2002;17:A103.
   PubMedGoogle Scholar
• Begtrup LM, Engsbro AL, Kjeldsen J, Larsen PV, de Muckadell OS, Bytzer P, et al. A positive diagnostic strategy is non-inferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:956–62.
   PubMed Web of Science ®Google Scholar
• Scicluna SM, Tawari B, Clark CG. DNA barcoding of blastocystis. Protist 2006;157:77–85.
   PubMed Web of Science ®Google Scholar
• Stensvold CR, Jespersgaard C, Dinesen K, Sørensen JF, Mølbak K, Nielsen HV, et al. Prevalence of Dientamoeba fragilis genotypes in different Danish populations as assessed by PCR and SNP genotyping. Trop Med Int Health 2007;12(Suppl):182.
   Google Scholar
• Verweij JJ, Blange RA, Templeton K, Schinkel J, Brienen EA, van Rooyen MA, et al. Simultaneous detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum in fecal samples by using multiplex real-time PCR. J Clin Microbiol 2004;42:1220–3.
   PubMed Web of Science ®Google Scholar
• Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg 2012;87:1046–52.
   PubMed Web of Science ®Google Scholar
• Roser D, Simonsen J, Nielsen HV, Stensvold CR, Molbak K. Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur J Clin Microbiol Infect Dis 2013;32:1303–10.
   PubMed Web of Science ®Google Scholar
• Roser D, Nejsum P, Carlsgart AJ, Nielsen HV, Stensvold CR. DNA of Dientamoeba fragilis detected within surface- sterilized eggs of Enterobius vermicularis. Exp Parasitol 2013;133:57–61.
   PubMedGoogle Scholar
• Ohman L, Simren M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 2013;15:323.
   PubMedGoogle Scholar
• Surangsrirat S, Thamrongwittawatpong L, Piyaniran W, Naaglor T, Khoprasert C, Taamasri P, et al. Assessment of the association between Blastocystis infection and irritable bowel syndrome. J Med Assoc Thai 2010;93(Suppl 6):S119–24.
   Google Scholar
• Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, et al. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 2004; 35:705–10.
   PubMedGoogle Scholar
• Cekin AH, Cekin Y, Adakan Y, Tasdemir E, Koclar FG, Yolcular BO. Blastocystosis in patients with gastrointestinal symptoms: a case–control study. BMC Gastroenterol 2012;12:122.
   PubMedGoogle Scholar
• Ramirez-Miranda ME, Hernandez-Castellanos R, Lopez-Escamilla E, Moncada D, Rodriguez-Magallan A, Pagaza-Melero C, et al. Parasites in Mexican patients with irritable bowel syndrome: a case–control study. Parasit Vectors 2010;3:96.
   PubMedGoogle Scholar
• Stensvold CR, Lewis HC, Hammerum AM, Porsbo LJ, Nielsen SS, Olsen KE, et al. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 2009;137:1655–63.
   PubMed Web of Science ®Google Scholar
• Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, et al. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 2003;10:128–30.
   PubMed Web of Science ®Google Scholar
• Rossignol JF, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005;3:987–91.
   PubMedGoogle Scholar
• Vogelberg C, Stensvold CR, Monecke S, Ditzen A, Stopsack K, Heinrich-Grafe U, et al. Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. Parasitol Int 2010;59:469–71.
   PubMedGoogle Scholar
• Stensvold CR, Alfellani M, Clark CG. Levels of genetic diversity vary dramatically between Blastocystis subtypes. Infect Genet Evol 2012;12:263–73.
   PubMedGoogle Scholar